Posted on 11/08/2010 in Pharmaceutical Company Financials Orion has seen a year-on-year increase in its net sales during the first half of 2010.
The pharmaceutical company has published its interim report for the January to June period, detailing a 422 million euro (349.7 million pounds) sales total for the six months, up by nine per cent year-on-year.
Profits, earnings and cash flow also increased during the same period, with Orion president and chief executive officer Timo Lappalainen highlighting the strong performance of its Parkinson's disease portfolio and European sales.
Mr Lappalainen stated that the company's strategy moving forward will be to focus on enhancing its product range, making its business more efficient and strengthening its European market base.
He added: "One key prerequisite for achieving this is continuous enhancement of our capability to network and collaborate with partners at all stages of the value chain."
Earlier this year, Orion announced the appointment of Satu Ahomaki as senior vice-president of global sales, replacing Pekka Kaivola as of October 1st 2010. Other news stories from 11/08/2010
Read more in the Zenopa News Archive
How this news is generated
|
